Bottom line
SWHFX vs HRTS: the short answer
SWHFX (Schwab Health Care Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 57% by weight.
HRTS is cheaper at 0.75% vs 0.8% — a difference of $5.00 a year per $10,000 invested.
Over one year, HRTS returned +23.6% vs +15.9% for SWHFX.
Updated Nov 19, 2026
SWHFX vs HRTS side by side
| SWHFX | HRTS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Schwab | Innovator |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 0.75% |
| Annual cost per $10k | $80 | $75 |
| 10-yr cost on $10k (prospectus) | $990 | $1,168 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +15.9% | +23.6% |
| 5-yr return (annualized) | +6.5% | — |
| 10-yr return (annualized) | +8.1% | — |
| Best quarter | +15.3% | +15.8% |
| Worst quarter | −12.1% | −12.4% |
| Net assets (fund) | $642.3M | $51.9M |
| Number of holdings | 80 | 45 |
| Portfolio turnover | 41% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWHFX | HRTS | Difference |
|---|---|---|---|
| 2025 | +15.9% | +23.6% | −7.7% |
| 2024 | +0.1% | +3.6% | −3.5% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SWHFX's top 25 holdings also appear in HRTS's top 25.
| Holding | SWHFX | HRTS |
|---|---|---|
| Eli Lilly & Co | 13.92% | 11.52% |
| Johnson & Johnson | 6.94% | 3.59% |
| AbbVie Inc | 5.81% | 2.40% |
| Merck & Co Inc | 4.98% | 4.27% |
| UnitedHealth Group Inc | 4.74% | 5.24% |
| Gilead Sciences Inc | 3.24% | 3.43% |
| Novartis AG | 2.92% | 3.38% |
| Amgen Inc | 2.58% | 1.91% |
| Bristol-Myers Squibb Co | 2.44% | 2.09% |
| Medtronic PLC | 2.29% | 1.88% |
| Thermo Fisher Scientific Inc | 2.16% | 3.97% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.93% |
| Abbott Laboratories | 1.60% | 2.61% |
| Danaher Corp | 1.47% | 2.66% |
Source: SEC Form N-PORT
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
FAQ
What is the difference between SWHFX and HRTS?
Which is cheaper, SWHFX or HRTS?
Should I own both SWHFX and HRTS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.